These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 7801148
1. The role of granulocyte-macrophage colony-stimulating factor in the treatment of germ cell tumors. German Testicular Cancer Study Group. Bokemeyer C, Harstrick A, Rüther U, Metzner B, Illiger HJ, Clemm C, Siegert W, Link H, Ostermann H, Schmoll HJ. Semin Oncol; 1994 Dec; 21(6 Suppl 16):57-63. PubMed ID: 7801148 [Abstract] [Full Text] [Related]
2. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group. Bokemeyer C, Harstrick A, Beyer J, Metzner B, Rüther U, Hartmann JT, Holstein K, Derigs HG, de Wit R, Casper J, Schöffski P, Kührer I, Illiger HJ, Kempf B, Reichle A, Föller A, Hossfeld DK, Fischer JT, Berdel WE, Gerhartz HH, Kirchner H, Pflüger KH, Ostermann H, Kanz L, Schmoll HJ. Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059 [Abstract] [Full Text] [Related]
3. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group. Schmoll HJ, Kollmannsberger C, Metzner B, Hartmann JT, Schleucher N, Schöffski P, Schleicher J, Rick O, Beyer J, Hossfeld D, Kanz L, Berdel WE, Andreesen R, Bokemeyer C, German Testicular Cancer Study Group. J Clin Oncol; 2003 Nov 15; 21(22):4083-91. PubMed ID: 14568987 [Abstract] [Full Text] [Related]
4. Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group. Hartmann JT, Gauler T, Metzner B, Gerl A, Casper J, Rick O, Horger M, Schleicher J, Derigs G, Mayer-Steinacker R, Beyer J, Kuczyk MA, Bokemeyer C, German Testicular Cancer Study Group. J Clin Oncol; 2007 Dec 20; 25(36):5742-7. PubMed ID: 18089869 [Abstract] [Full Text] [Related]
5. Sequential intermediate high-dose therapy with etoposide, ifosfamide and cisplatin for patients with germ cell tumors. Mardiak J, Fuchsberger P, Lakota J, Sálek T, Sycová-Milá Z, Drahokoupilová M, Baláz M, Koza I. Neoplasma; 2000 Dec 20; 47(4):239-43. PubMed ID: 11043829 [Abstract] [Full Text] [Related]
6. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996]. Fléchon A, Biron P, Philip I, Blay JY, Droz JP. Bull Cancer; 1999 Apr 20; 86(4):391-9. PubMed ID: 10341344 [Abstract] [Full Text] [Related]
7. [High-dose chemotherapy with peripheral blood stem cell transplantation for advanced testicular cancer]. Hasumi H, Kishida T, Teranishi J, Nakaigawa N, Fujinami K, Ikeda I, Uemura H, Yao M, Takeda M, Noguchi S, Kubota Y. Hinyokika Kiyo; 2002 Aug 20; 48(8):469-73. PubMed ID: 12243071 [Abstract] [Full Text] [Related]
8. [High dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) For advanced testicular cancer]. Fujii Y, Kihara K, Kamata S, Tsujii T, Ishizaka K, Kageyama Y, Masuda H, Arisawa C, Oshima H, Komatsu F. Hinyokika Kiyo; 1998 May 20; 44(5):313-8. PubMed ID: 9656101 [Abstract] [Full Text] [Related]
9. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma. Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ. Biol Blood Marrow Transplant; 2004 Jun 20; 10(6):395-404. PubMed ID: 15148493 [Abstract] [Full Text] [Related]
13. [High-dose chemotherapy with peripheral blood stem cell autotransplantation for patients with poor-risk testicular germ cell tumors--pilot study of the Japan Blood Cell Transplantation Study Group]. Nakagawa S, Miki T, Akaza H, Ozono S, Okano T, Sonoda Y, Tsukamoto T, Terachi T, Naito K, Naito S, Nishiyama T, Nonomura N, Hara I, Hoshi S, Yoshida O. Hinyokika Kiyo; 1999 Nov 20; 45(11):805-9. PubMed ID: 10637748 [Abstract] [Full Text] [Related]
15. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells. Hohaus S, Martin H, Wassmann B, Egerer G, Haus U, Färber L, Burger KJ, Goldschmidt H, Hoelzer D, Haas R. Bone Marrow Transplant; 1998 Oct 20; 22(7):625-30. PubMed ID: 9818688 [Abstract] [Full Text] [Related]